针对线粒体的光热化学动力疗法增强了对结肠癌的检查点阻塞免疫疗法
Benchao Zheng1,2, Hongbo Wang1,2, Shiyi Zhai1,2
1Institute of Medical Technology, Peking University Health Science Center, Beijing, 100191, PR China.
Materials today. Bio
|February 28, 2025
概括
针对线粒体的光热和化学动力学疗法与免疫疗法相结合,可以消灭原发性瘤并抑制远部瘤. 这种组合疗法激活了免疫反应,提高了癌症治疗的疗效.
科学领域:
- 纳米医学是一种纳米医学.
- 癌症免疫疗法癌症免疫疗法
- 光热疗法 光热疗法
- 化学动力学疗法 化学动力学疗法
- 线粒体向定位 线粒体向
背景情况:
- 癌症免疫疗法显示出有希望的结果,但单一疗法反应率有限.
- 光热疗法 (PTT) 可以通过损伤相关分子模式 (DAMPs) 释放激活抗瘤免疫反应.
- 线粒体损伤与PTT诱导的免疫激活有关,这表明针对线粒体的PTT可以增强免疫疗法协同作用.
研究的目的:
- 开发一种针对线粒体的纳米平台,用于联合光热和化学动力学疗法 (PTT/CDT).
- 研究这种PTT/CDT纳米平台与检查点阻断免疫疗法 (抗PD-1) 的协同效应.
- 在临床前癌症模型中评估治疗疗效和免疫激活.
主要方法:
- 在聚乙烯 (PVP) 覆盖的金铜纳米颗粒 (AIT) 上,印氨酸绿 (ICG-SH) 和甲三 (TPP-SH) 的结合.
- 针对线粒体的PTT/CDT结合抗PD-1 (αPD-1) 免疫疗法在双边小鼠结肠癌模型中.
- 评估瘤切除,远程瘤抑制,血清促炎因子水平,树突细胞 (DC) 透和CD8+T细胞透.
主要成果:
- 艾特纳米颗粒激活了针对线粒体的PTT/CDT,诱导癌细胞亡并放大治疗效果.
- 组合疗法 (AIT + αPD-1) 完全消除了原发性瘤,并显著抑制了远部未经治疗的瘤.
- 治疗显著增加了促炎性细胞因子 (IL-6,IFN-γ,TNF-α),增强了DC和CD8+T细胞透,表明强大的免疫激活.
结论:
- 针对线粒体的PTT/CDT与检查点阻塞免疫疗法有效协同作用.
- 这种组合策略增强了免疫细胞死亡,克服了单一治疗的局限性.
- 线粒体向是一种有前途的方法,可以增强转移性疾病的组合癌症疗法.
更多相关视频
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
7.8K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.0K
相关概念视频
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Electron Transport Chain: Complex I and II
10.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.1K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
